Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP285714.RAcF3wmzEigQOwvKTjQYlCr0ccWwl4iddkNB8pI85HbPU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP285714.RAcF3wmzEigQOwvKTjQYlCr0ccWwl4iddkNB8pI85HbPU130_assertion type Assertion NP285714.RAcF3wmzEigQOwvKTjQYlCr0ccWwl4iddkNB8pI85HbPU130_head.
- NP285714.RAcF3wmzEigQOwvKTjQYlCr0ccWwl4iddkNB8pI85HbPU130_assertion description "[Core binding factor acute myeloid leukemia (CBF AML), with t(8;21)(q22;q22), inv(16)(p13q22) or t(16;16)(p13;q22) and the associated fusion gene transcripts AML1/ETO or CBFbeta/MYH11, has a favourable clinical prognosis although significant numbers of patients still suffer relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285714.RAcF3wmzEigQOwvKTjQYlCr0ccWwl4iddkNB8pI85HbPU130_provenance.
- NP285714.RAcF3wmzEigQOwvKTjQYlCr0ccWwl4iddkNB8pI85HbPU130_assertion evidence source_evidence_literature NP285714.RAcF3wmzEigQOwvKTjQYlCr0ccWwl4iddkNB8pI85HbPU130_provenance.
- NP285714.RAcF3wmzEigQOwvKTjQYlCr0ccWwl4iddkNB8pI85HbPU130_assertion SIO_000772 18297529 NP285714.RAcF3wmzEigQOwvKTjQYlCr0ccWwl4iddkNB8pI85HbPU130_provenance.
- NP285714.RAcF3wmzEigQOwvKTjQYlCr0ccWwl4iddkNB8pI85HbPU130_assertion wasDerivedFrom befree-20150227 NP285714.RAcF3wmzEigQOwvKTjQYlCr0ccWwl4iddkNB8pI85HbPU130_provenance.
- NP285714.RAcF3wmzEigQOwvKTjQYlCr0ccWwl4iddkNB8pI85HbPU130_assertion wasGeneratedBy ECO_0000203 NP285714.RAcF3wmzEigQOwvKTjQYlCr0ccWwl4iddkNB8pI85HbPU130_provenance.